iRadimed
IRMD
62 hedge funds and large institutions have $96.8M invested in iRadimed in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 29 reducing their positions, and 8 closing their positions.
0.57% less ownership
Funds ownership: 37.44% → 36.88% (-0.57%)
5% less funds holding
Funds holding: 65 → 62 (-3)
8% less capital invested
Capital invested by funds: $105M → $96.8M (-$7.97M)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
38% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 29
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
+$2.99M |
| 2 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.64M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$1.08M |
| 4 |
Renaissance Technologies
New York
|
+$858K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$492K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$2.2M |
| 2 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$1.19M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$941K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$683K |
| 5 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$591K |
IRMD Hedge Fund Activity: Q3 2020 in Review
62 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q3 2020, worth a combined $96.8M — down 7.6% from $105M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IRMD and 5 opened new positions — a net loss of 3 holders — while 29 trimmed existing stakes and 18 added.
The largest buyer was Nine Ten Capital Management, adding an estimated $2.99M. The largest seller was Parkman Healthcare Partners, exiting entirely with an estimated $2.2M sold.
- 62 institutional investors held iRadimed (IRMD) as of Q3 2020, down from 65 in Q2 2020.
- Funds reported $96.8M of iRadimed stock for Q3 2020, down 7.6% quarter-over-quarter.
- 5 funds opened new iRadimed positions in Q3 2020 and 8 closed out, a net change of -3 holders.
- The largest iRadimed buyer in Q3 2020 was Nine Ten Capital Management, an estimated $2.99M added.
- The largest iRadimed seller in Q3 2020 was Parkman Healthcare Partners, an estimated $2.2M sold.
Based on aggregated 13F filings for Q3 2020.